⌘K

Login Start Free

Home/Filings/4/0001562180-19-006150

4//SEC Filing

Mims David W. 4

Accession 0001562180-19-006150

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 3:16 PM ET

Size

5.3 KB

Accession

0001562180-19-006150

Insider Transaction Report

Form 4

Period: 2019-12-13

PROGENICS PHARMACEUTICALS INCPGNX

10% OwnerOther

Transactions

Award
Non-Qualified Stock Option (Right to Buy)
2019-12-13+16,393→ 16,393 total
Exercise: $5.01From: 2019-12-13Exp: 2029-12-13→ Common Stock (16,393 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable immediately on the date of grant.

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001789675

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 3:16 PM ET
Size: 5.3 KB

View on SEC.gov